Use in the elderly The efficacy and safety of strontium ranelate have been established in a broad age range (up to 100 years at inclusion) of postmenopausal women with osteoporosis.
Kasutamine eakatel Strontsiumranelaadi toime ja ohutus on kindlaks määratud laias vanusevahemikus (uuringusse lülitamisel vanuses kuni 100 aastat) osteoporoosiga postmenopausis naistel.